The open index of psychedelic research

562. Repeated psilocybin administration does not induce rewarding effects and increases ventral tegmental dopaminergic activity during withdrawal

828. Psilocin attenuates polyinosinic:polycytidylic acid (Poly I:C)-indued interferon responses in human peripheral blood mononuclear cells

444. In depth behavioral phenotyping of sex-dependent consequences of maternal separation in mice and effects of psilocybin

Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations

Reply: The consequences of MDMA use are not easily disentangled from other drug use or lifestyle factors.

Quednow BB, Coray RC

832. The Maudsley Advanced Treatment Service: Maudsley Ketamine Clinical Research Experience

[An unusual presentation of syndrome of inappropriate antidiuretic hormone secretion - When things aren't what they seem].

Jiménez Hernando I, Gómez-Gordo Hernanz M, Pérez Noguero M +1

The consequences of MDMA use are not easily disentangled from other drug use or lifestyle factors.

Basedow LA

Esketamine Ameliorates Propofol-Induced Long-Term Cognitive Impairments in Juvenile Rats by Suppressing Autophagy via Activating the PI3K/Akt/mTOR Signaling Pathway.

Wang Y, Li Y, Chen Z +4

Correction: Electrocardiographic and echocardiographic profiles of white-lipped peccaries (<i>Tayassu pecari</i>) under ketamine-dexmedetomidine or ketamine-midazolam anesthesia.

Gorczak R, Valandro MA, Barbosa HB +2

551. Esketamine in neuropsychiatric long COVID: a retrospective analysis

753. The Mechanism of Ketamine’s Anti-Suicidal Action: From Glutamatergic Surge to Neuroplasticity via the Opioid-Attachment Interface

Continuing Questions About Esketamine 5 Years After Approval: Response to Ahmed et al.

Schatzberg AF, Fountoulakis KN

384. S-ketamine, but not R-ketamine, increases the spontaneous firing rate and the AMPA-evoked response of pyramidal neurons in the rat prefrontal cortex

Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder

224. Biomarkers of ketamine efficacy: role of the kynurenine pathway

Pharmacological interventions for alcohol use disorder on quality of life: a meta-analysis of randomized controlled trials.

Fluyau D, Revadigar N, Kim P

Safety Effect Moderators of Intranasal Esketamine used in Assocation with a SSRI or SNRI: An Individual Participant Data Meta-Analysis

643. A mechanism-informed clinical trial of psilocybin-assisted therapy for opioid use disorder: rationale and neurobiological framework

252. Clinical application of psychedelic-assisted therapy in major depression and addictions

The trials of translating psilocybin treatment from research to practice.

Galindo L, Ragnhildstveit A, Illingworth BJG

47. Early improvement predicts subsequent antidepressant response to intravenous ketamine

457. Intensive longitudinal monitoring of symptoms in response to treatment with intranasal esketamine

326. Ketamine-induced changes of cerebral glucose metabolism in healthy humans: evidence from [18F]FDG functional PET